Gary R.  Maharaj net worth and biography

Gary Maharaj Biography and Net Worth

CEO of Surmodics
Gary R. Maharaj is President and Chief Executive Officer. He also serves as a member of Surmodics' Board of Directors. Prior to joining Surmodics in December 2010, Gary served as President and Chief Executive Officer of Arizant Inc., from 2006 to 2010. Previously, he served in several senior level management positions for Augustine Medical, Inc. (predecessor to Arizant Inc.) from 1996 to 2006, including Vice President of Marketing and Vice President of Research and Development. He also served in various management and research positions for the orthopedic implant and rehabilitation divisions of Smith & Nephew, PLC. Gary holds an MBA from the University of Minnesota's Carlson School of Management, an M.S. in biomedical engineering from the University of Texas at Arlington and the University of Texas Southwestern Medical Center at Dallas, and a B.Sc. in Physics from the University of the West Indies.

What is Gary R. Maharaj's net worth?

The estimated net worth of Gary R. Maharaj is at least $6.07 million as of April 1st, 2022. Mr. Maharaj owns 155,041 shares of Surmodics stock worth more than $6,069,855 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Maharaj may own. Additionally, Mr. Maharaj receives a salary of $1,330,000.00 as CEO at Surmodics. Learn More about Gary R. Maharaj's net worth.

How old is Gary R. Maharaj?

Mr. Maharaj is currently 61 years old. There are 6 older executives and no younger executives at Surmodics. Learn More on Gary R. Maharaj's age.

What is Gary R. Maharaj's salary?

As the CEO of Surmodics, Inc., Mr. Maharaj earns $1,330,000.00 per year. Learn More on Gary R. Maharaj's salary.

How do I contact Gary R. Maharaj?

The corporate mailing address for Mr. Maharaj and other Surmodics executives is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. Surmodics can also be reached via phone at (952) 500-7000 and via email at [email protected]. Learn More on Gary R. Maharaj's contact information.

Has Gary R. Maharaj been buying or selling shares of Surmodics?

Gary R. Maharaj has not been actively trading shares of Surmodics in the last ninety days. Most recently, Gary R. Maharaj sold 4,000 shares of the business's stock in a transaction on Friday, April 1st. The shares were sold at an average price of $44.99, for a transaction totalling $179,960.00. Following the completion of the sale, the chief executive officer now directly owns 155,041 shares of the company's stock, valued at $6,975,294.59. Learn More on Gary R. Maharaj's trading history.

Who are Surmodics' active insiders?

Surmodics' insider roster includes Jose Bedoya (Director), David Dantzker (Director), Gary Maharaj (CEO), John Manders (Insider), Charles Olson (VP), and Joseph Stich (SVP). Learn More on Surmodics' active insiders.

Gary R. Maharaj Insider Trading History at Surmodics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2022Sell4,000$44.99$179,960.00155,041View SEC Filing Icon  
11/1/2021Sell6,000$54.65$327,900.00View SEC Filing Icon  
9/15/2021Sell6,000$57.23$343,380.00View SEC Filing Icon  
1/4/2021Sell2,000$43.96$87,920.00145,142View SEC Filing Icon  
9/1/2020Sell3,000$45.07$135,210.00View SEC Filing Icon  
7/1/2020Sell2,000$43.02$86,040.00View SEC Filing Icon  
1/2/2020Sell702$41.08$28,838.16142,885View SEC Filing Icon  
12/2/2019Sell5,000$40.39$201,950.00144,317View SEC Filing Icon  
11/1/2019Sell5,000$40.59$202,950.00128,153View SEC Filing Icon  
10/1/2019Sell5,000$45.50$227,500.00132,953View SEC Filing Icon  
9/3/2019Sell5,000$45.95$229,750.00View SEC Filing Icon  
8/1/2019Sell5,000$46.50$232,500.00144,975View SEC Filing Icon  
7/1/2019Sell5,000$42.66$213,300.00150,235View SEC Filing Icon  
6/3/2019Sell5,000$40.95$204,750.00152,205View SEC Filing Icon  
5/1/2019Sell5,000$42.68$213,400.00157,205View SEC Filing Icon  
4/1/2019Sell5,000$42.90$214,500.00View SEC Filing Icon  
2/1/2019Sell2,833$53.45$151,423.85170,767View SEC Filing Icon  
1/2/2019Sell5,000$46.22$231,100.00174,967View SEC Filing Icon  
12/3/2018Sell5,000$59.35$296,750.00View SEC Filing Icon  
11/1/2018Sell5,000$62.21$311,050.00166,086View SEC Filing Icon  
10/1/2018Sell5,000$72.35$361,750.00170,767View SEC Filing Icon  
8/1/2018Sell5,000$58.93$294,650.00174,586View SEC Filing Icon  
7/2/2018Sell5,000$54.48$272,400.00179,586View SEC Filing Icon  
8/7/2017Sell5,000$25.75$128,750.00126,807View SEC Filing Icon  
7/3/2017Sell5,000$28.03$140,150.00131,807View SEC Filing Icon  
6/5/2017Sell2,702$25.09$67,793.18136,807View SEC Filing Icon  
4/3/2017Sell584$25.00$14,600.00View SEC Filing Icon  
11/7/2016Sell5,000$25.22$126,100.00130,207View SEC Filing Icon  
10/3/2016Sell5,000$29.55$147,750.00View SEC Filing Icon  
See Full Table

Gary R. Maharaj Buying and Selling Activity at Surmodics

This chart shows Gary R Maharaj's buying and selling at Surmodics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Surmodics Company Overview

Surmodics logo
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Read More

Today's Range

Now: $39.15
Low: $39.08
High: $39.24

50 Day Range

MA: $38.49
Low: $37.50
High: $39.44

2 Week Range

Now: $39.15
Low: $25.17
High: $42.44

Volume

24,083 shs

Average Volume

229,644 shs

Market Capitalization

$558.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2